Pankaj Goyal Goel|Pankaj Goyal

Pankaj Goyal Goel|Pankaj Goyal

EU Business School - Geneva / Switzerland
Business & Management / Business Administration
AD Scientific Index ID: 1091702
-
person_outline Pankaj Goyal Goel|Pankaj Goyal's MOST POPULAR ARTICLES
1-) Long-term triple therapy de-escalation to indacaterol/glycopyrronium in patients with chronic obstructive pulmonary disease (SUNSET): a randomized, double-blind, triple-dummy …KR Chapman, JR Hurst, SM Frent, M Larbig, R Fogel, T Guerin, D Banerji, ...American journal of respiratory and critical care medicine 198 (3), 329-339, 20181912018
2-) Efficacy and safety of coadministration of once-daily indacaterol and glycopyrronium versus indacaterol alone in COPD patients: the GLOW6 studyW Vincken, J Aumann, H Chen, M Henley, D McBryan, P GoyalInternational journal of chronic obstructive pulmonary disease 9, 215, 2014912014
3-) Optimizing identification and management of COPD patients–reviewing the role of the community pharmacistT van der Molen, JFM van Boven, T Maguire, P Goyal, P AltmanBritish Journal of Clinical Pharmacology 83 (1), 192-201, 2017622017
4-) Comparison of peak inspiratory flow rate via the Breezhaler®, Ellipta® and HandiHaler® dry powder inhalers in patients with moderate to very severe COPD: a randomized cross …P Altman, L Wehbe, J Dederichs, T Guerin, B Ament, MC Moronta, ...BMC pulmonary medicine 18, 1-8, 2018662018
5-) Comparative efficacy of long-acting β2-agonists as monotherapy for chronic obstructive pulmonary disease: a network meta-analysisJF Donohue, KA Betts, EX Du, P Altman, P Goyal, DL Keininger, ...International journal of chronic obstructive pulmonary disease, 367-381, 2017472017